Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07239076
Recruiting Not applicable

Unstimulated Gluteus Maximus Sphincteroplasty for Treatment of Bowel Incontinnence Case Series Study

NCT07239076 · tracked via the Priya Life Science Egypt tracker
Sponsor
Assiut University
Phase
Not applicable
Started
2025-07-01
Last updated
2025-11-20

Condition(s) studied

Bowel Incontinence

Investigational drug(s) / intervention(s)

Unstimulated gluteus maximus sphincteroplasty

Unstimulated gluteus maximus sphincteroplasty: Surgery done under general anethesia prone jacknige postion .. incsion made along lower gluteal crease to take lower third fibers including neurovascular bundle and dicussating subcutaneusly around anus and suturing on contralateral ischial tuberosity

Study summary

Unstimlated gluteus maximus sphincteroplasty for treatment of bowle incontinence

Eligibility

Sex
ALL
Min age
9 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * patients with severe fecal incontinence refractory to medical treatment * loss of native anal sphincter confirmed by MRI * patients deemed suitable for unstimulated gluteus maximus sphincteroplasty Exclusion Criteria: * amyotrophic lateral sclerosis * severe scarring of bilateral gluteus maximus * pelvic fracture with injury of internal illiac vessels

Primary outcome measure(s)

  • Improvement of fecal incontinence — 6 months
    Improvement of fecal incontince assessed by cleveland clinic florida fecal incontinnence score \<7
  • Improvement of fecal incontinence — 6 months
    Improvement of fecal incontinence assessed by cleveland clinic florida fecal incontinence score at final follow uo \<7

Trial sites (1)

FacilityCityRegionStatus
Assiut hospital university Asyut University Recruiting

More Assiut University trials in Egypt

Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder Recruiting
The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion Starting soon
Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores Starting soon
Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH Starting soon
Intraoperative Lidocaine Infusion Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07239076 on ClinicalTrials.gov ↗ ← All trials in Egypt